Advertisement
Turning AI ambition into measurable results in life sciencesAbout this Event
Commercial teams across pharma and biotech are investing heavily in AI, from next-best-action to forecasting, but as 2027 planning begins, the pressure to show measurable returns is rising. Join Catalant's CEO Pat Petitti and a small group of C-suite and VP-level commercial leaders for an intimate conversation about what’s actually working, where pilots are stalling, and how leaders are tying AI investments to results the business can see. Join us for dinner and candid conversation at the lovely Contessa restaurant on Newbury Street.
Advertisement
Event venue & nearby stays
Contessa Boston, 3 Newbury Street, Boston, United States
Tickets
USD 0.00
Discover more events by tag
Technology in BostonArtificial-intelligence in BostonData-science in BostonMachine-learning in BostonBusiness in BostonLeadership in BostonMarketing in Boston